Global Antivirals Market Research Report 2023(Status and Outlook)


Attention: There is an updated edition available for this report.

BSR000150894


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Antivirals
1.2 Key Market Segments
1.2.1 Antivirals Segment by Type
1.2.2 Antivirals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Antivirals Market Overview
2.1 Global Market Overview
2.1.1 Global Antivirals Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Antivirals Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Antivirals Market Competitive Landscape
3.1 Global Antivirals Sales by Manufacturers (2018-2023)
3.2 Global Antivirals Revenue Market Share by Manufacturers (2018-2023)
3.3 Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antivirals Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Antivirals Sales Sites, Area Served, Product Type
3.6 Antivirals Market Competitive Situation and Trends
3.6.1 Antivirals Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antivirals Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Antivirals Industry Chain Analysis
4.1 Antivirals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Antivirals Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Antivirals Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antivirals Sales Market Share by Type (2018-2023)
6.3 Global Antivirals Market Size Market Share by Type (2018-2023)
6.4 Global Antivirals Price by Type (2018-2023)
7 Antivirals Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antivirals Market Sales by Application (2018-2023)
7.3 Global Antivirals Market Size (M USD) by Application (2018-2023)
7.4 Global Antivirals Sales Growth Rate by Application (2018-2023)
8 Antivirals Market Segmentation by Region
8.1 Global Antivirals Sales by Region
8.1.1 Global Antivirals Sales by Region
8.1.2 Global Antivirals Sales Market Share by Region
8.2 North America
8.2.1 North America Antivirals Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antivirals Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antivirals Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antivirals Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antivirals Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Antivirals Basic Information
9.1.2 Merck Antivirals Product Overview
9.1.3 Merck Antivirals Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Antivirals SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Johnson andamp; Johnson
9.2.1 Johnson andamp; Johnson Antivirals Basic Information
9.2.2 Johnson andamp; Johnson Antivirals Product Overview
9.2.3 Johnson andamp; Johnson Antivirals Product Market Performance
9.2.4 Johnson andamp; Johnson Business Overview
9.2.5 Johnson andamp; Johnson Antivirals SWOT Analysis
9.2.6 Johnson andamp; Johnson Recent Developments
9.3 Teva Pharmaceutical Industries
9.3.1 Teva Pharmaceutical Industries Antivirals Basic Information
9.3.2 Teva Pharmaceutical Industries Antivirals Product Overview
9.3.3 Teva Pharmaceutical Industries Antivirals Product Market Performance
9.3.4 Teva Pharmaceutical Industries Business Overview
9.3.5 Teva Pharmaceutical Industries Antivirals SWOT Analysis
9.3.6 Teva Pharmaceutical Industries Recent Developments
9.4 GSK
9.4.1 GSK Antivirals Basic Information
9.4.2 GSK Antivirals Product Overview
9.4.3 GSK Antivirals Product Market Performance
9.4.4 GSK Business Overview
9.4.5 GSK Antivirals SWOT Analysis
9.4.6 GSK Recent Developments
9.5 Mylan
9.5.1 Mylan Antivirals Basic Information
9.5.2 Mylan Antivirals Product Overview
9.5.3 Mylan Antivirals Product Market Performance
9.5.4 Mylan Business Overview
9.5.5 Mylan Antivirals SWOT Analysis
9.5.6 Mylan Recent Developments
9.6 Gilead Sciences
9.6.1 Gilead Sciences Antivirals Basic Information
9.6.2 Gilead Sciences Antivirals Product Overview
9.6.3 Gilead Sciences Antivirals Product Market Performance
9.6.4 Gilead Sciences Business Overview
9.6.5 Gilead Sciences Recent Developments
9.7 F. Hoffmann-La Roche
9.7.1 F. Hoffmann-La Roche Antivirals Basic Information
9.7.2 F. Hoffmann-La Roche Antivirals Product Overview
9.7.3 F. Hoffmann-La Roche Antivirals Product Market Performance
9.7.4 F. Hoffmann-La Roche Business Overview
9.7.5 F. Hoffmann-La Roche Recent Developments
9.8 Bristol-Myers-Squibb
9.8.1 Bristol-Myers-Squibb Antivirals Basic Information
9.8.2 Bristol-Myers-Squibb Antivirals Product Overview
9.8.3 Bristol-Myers-Squibb Antivirals Product Market Performance
9.8.4 Bristol-Myers-Squibb Business Overview
9.8.5 Bristol-Myers-Squibb Recent Developments
9.9 AbbVie
9.9.1 AbbVie Antivirals Basic Information
9.9.2 AbbVie Antivirals Product Overview
9.9.3 AbbVie Antivirals Product Market Performance
9.9.4 AbbVie Business Overview
9.9.5 AbbVie Recent Developments
9.10 Aurobindo Pharma
9.10.1 Aurobindo Pharma Antivirals Basic Information
9.10.2 Aurobindo Pharma Antivirals Product Overview
9.10.3 Aurobindo Pharma Antivirals Product Market Performance
9.10.4 Aurobindo Pharma Business Overview
9.10.5 Aurobindo Pharma Recent Developments
9.11 Cipla
9.11.1 Cipla Antivirals Basic Information
9.11.2 Cipla Antivirals Product Overview
9.11.3 Cipla Antivirals Product Market Performance
9.11.4 Cipla Business Overview
9.11.5 Cipla Recent Developments
9.12 Dr Reddy’s
9.12.1 Dr Reddy’s Antivirals Basic Information
9.12.2 Dr Reddy’s Antivirals Product Overview
9.12.3 Dr Reddy’s Antivirals Product Market Performance
9.12.4 Dr Reddy’s Business Overview
9.12.5 Dr Reddy’s Recent Developments
10 Antivirals Market Forecast by Region
10.1 Global Antivirals Market Size Forecast
10.2 Global Antivirals Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antivirals Market Size Forecast by Country
10.2.3 Asia Pacific Antivirals Market Size Forecast by Region
10.2.4 South America Antivirals Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antivirals by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Antivirals Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Antivirals by Type (2024-2029)
11.1.2 Global Antivirals Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Antivirals by Type (2024-2029)
11.2 Global Antivirals Market Forecast by Application (2024-2029)
11.2.1 Global Antivirals Sales (K MT) Forecast by Application
11.2.2 Global Antivirals Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings